The board of CHD Chemicals at its meeting held on 08 September 2026 has approved the proposal to increase the authorised share capital of the company. According to reports from Business Standard, the board approved the creation of 2,50,00,000 additional equity shares of ₹10 each, bringing the total authorised share capital to ₹36 crore. The new shares will be divided into 3,60,00,000 equity shares of ₹10 each.
Under the approved proposal, the company's authorised share capital will increase significantly from the current ₹11 crore divided into 1,10,00,000 equity shares of ₹10 each. As reported by Business Standard, the new structure will result in 2,50,00,000 additional equity shares being added to the company's authorised capital base. The proposal is subject to approval from the company's members.
According to the board decision reported by Business Standard, the increase in authorised share capital will be achieved through the creation of additional equity shares. The proposal requires approval from the members before the increase can be implemented. This represents a substantial expansion of the company's share capital structure to support future business growth and fundraising requirements.
The company has demonstrated strong financial performance with net profit of ₹27,837.04 lakh for FY 2025-26, compared to ₹1,267.17 lakh in the previous year. The basic earnings per share increased significantly to ₹21.79 from ₹1.40 in the previous year. The company's total assets grew to ₹77,783.50 lakh from ₹40,239.17 lakh in the previous year, reflecting substantial business expansion.
As per the latest shareholding data, Mr. Abhishek Singhania holds 33.71% stake with 4,39,20,411 equity shares. J.K. Traders Limited holds 21.10% stake with 2,74,85,702 shares. The company's public shareholding stands at 34.81% with 85,712 shareholders holding 4,53,51,679 shares. The top 10 shareholders collectively hold 86.40% of the company's equity, indicating strong institutional and promoter confidence.
